Results 11 to 20 of about 3,844,733 (310)

Cancer Research UK Cancer Awareness Measures, 2014 [PDF]

open access: yes, 2022
copyright UK Data Service and data collection copyright owner.The Cancer Awareness Measure (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A.,
Cancer Research UK
core   +1 more source

Artificial Intelligence in Cancer Research: Trends, Challenges and Future Directions

open access: yesLife, 2022
The World Health Organization (WHO), in their 2022 report, identified cancer as one of the leading causes of death, accounting for about 16% of deaths worldwide.
Anu Maria Sebastian, David Peter
doaj   +1 more source

Shanghai expert consensus on whole-process management of antineoplastic-induced nausea and vomiting (2024 edition) [PDF]

open access: yesZhongguo aizheng zazhi
Nausea and vomiting are common adverse reactions in tumor patients during anti-tumor therapy such as chemotherapy, radiotherapy, targeted therapy and immunotherapy.
Cancer Rehabilitation and Palliative Professional Committee of Shanghai Anti-Cancer Association   +2 more
doaj   +2 more sources

Building capacity for clinical research in developing countries: the INDOX cancer research network experience [PDF]

open access: yesGlobal Health Action, 2012
Transnational Organisations increasingly prioritise the need to support local research capacity in low and middle income countries in order that local priorities are addressed with due consideration of contextual issues. There remains limited evidence on
Raghib Ali   +2 more
doaj   +1 more source

Integrating Artificial Intelligence Tools in the Clinical Research Setting: The Ovarian Cancer Use Case

open access: yesDiagnostics, 2023
Artificial intelligence (AI) methods applied to healthcare problems have shown enormous potential to alleviate the burden of health services worldwide and to improve the accuracy and reproducibility of predictions. In particular, developments in computer
Lorena Escudero Sanchez   +15 more
doaj   +1 more source

HER3 Is an Actionable Target in Advanced Prostate Cancer. [PDF]

open access: yes, 2021
It has been recognized for decades that ERBB signaling is important in prostate cancer, but targeting ERBB receptors as a therapeutic strategy for prostate cancer has been ineffective clinically.
Bertan, C   +44 more
core   +1 more source

Mutation of the STK11 gene predicts recurrence of breast cancer [PDF]

open access: yes, 2021
[[abstract]]Introduction: Breast cancer is the most common cancer in women, and some patients develop recurrence after standard therapy. Effective predictors are urgently needed to detect recurrence earlier.
Wang, CY;Chang, YC;Kuo, YL;Lee, KT;Chen, PS;Cheung, CHA;Shen, CH;Chang, CP;Lai, MD;Shen, MR;Hsu, HP
core   +1 more source

Comparison of factors influencing the willingness to donate biospecimens among guardians of children with cancer and adult cancer patients

open access: yesCancer Medicine, 2022
Background This study examined and compared the attitudes and willingness of guardians of children with cancer and adult cancer patients toward donating biospecimens and clinical data for cancer research.
Hongxiang Gao   +8 more
doaj   +1 more source

Current opportunities to catalyze research in nutrition and cancer prevention – an interdisciplinary perspective

open access: yesBMC Medicine, 2019
Cancer Research UK and Ludwig Cancer Research convened an inaugural international Cancer Prevention and Nutrition Conference in London on December 3–4, 2018.
The Cancer Research UK - Ludwig Cancer Research Nutrition and Cancer Prevention Collaborative Group
doaj   +1 more source

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium. [PDF]

open access: yes, 2007
Association studies in large series of breast cancer patients can be used to identify single-nucleotide polymorphisms (SNP) contributing to breast cancer susceptibility.
Pharoah, Paul DP   +22 more
core   +1 more source

Home - About - Disclaimer - Privacy